1. Home
  2. HUMA vs CHPT Comparison

HUMA vs CHPT Comparison

Compare HUMA & CHPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HUMA
  • CHPT
  • Stock Information
  • Founded
  • HUMA 2004
  • CHPT 2007
  • Country
  • HUMA United States
  • CHPT United States
  • Employees
  • HUMA N/A
  • CHPT N/A
  • Industry
  • HUMA Biotechnology: Pharmaceutical Preparations
  • CHPT Industrial Specialties
  • Sector
  • HUMA Health Care
  • CHPT Consumer Discretionary
  • Exchange
  • HUMA Nasdaq
  • CHPT Nasdaq
  • Market Cap
  • HUMA 250.2M
  • CHPT 340.1M
  • IPO Year
  • HUMA N/A
  • CHPT N/A
  • Fundamental
  • Price
  • HUMA $1.51
  • CHPT $11.29
  • Analyst Decision
  • HUMA Strong Buy
  • CHPT Hold
  • Analyst Count
  • HUMA 8
  • CHPT 10
  • Target Price
  • HUMA $10.88
  • CHPT $29.13
  • AVG Volume (30 Days)
  • HUMA 5.9M
  • CHPT 532.9K
  • Earning Date
  • HUMA 08-11-2025
  • CHPT 09-03-2025
  • Dividend Yield
  • HUMA N/A
  • CHPT N/A
  • EPS Growth
  • HUMA N/A
  • CHPT N/A
  • EPS
  • HUMA N/A
  • CHPT N/A
  • Revenue
  • HUMA $818,000.00
  • CHPT $407,681,000.00
  • Revenue This Year
  • HUMA N/A
  • CHPT $2.79
  • Revenue Next Year
  • HUMA $949.92
  • CHPT $24.20
  • P/E Ratio
  • HUMA N/A
  • CHPT N/A
  • Revenue Growth
  • HUMA N/A
  • CHPT N/A
  • 52 Week Low
  • HUMA $1.15
  • CHPT $8.55
  • 52 Week High
  • HUMA $6.77
  • CHPT $39.20
  • Technical
  • Relative Strength Index (RSI)
  • HUMA 36.87
  • CHPT 47.09
  • Support Level
  • HUMA $1.43
  • CHPT $11.41
  • Resistance Level
  • HUMA $1.67
  • CHPT $11.85
  • Average True Range (ATR)
  • HUMA 0.15
  • CHPT 0.59
  • MACD
  • HUMA -0.01
  • CHPT 0.08
  • Stochastic Oscillator
  • HUMA 23.32
  • CHPT 39.55

About HUMA Humacyte Inc.

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

About CHPT ChargePoint Holdings Inc.

ChargePoint Holdings Inc designs, develops, and markets networked electric vehicle charging system infrastructure and cloud-based services that enable consumers to locate, reserve, and authenticate EV charging. The company's hardware product lineup includes solutions across home, commercial, and fast-charging applications. ChargePoint derives the majority of its revenue from the United States.

Share on Social Networks: